Suitability of cefotiam and cefuroxime axetil for the perioperative short-term prophylaxis in tonsillectomy patientsMÜLLER, Rainer; BÖTTGER, Christina; WICHMANN, Georg et al.Arzneimittel-Forschung. 2003, Vol 53, Num 2, pp 126-132, issn 0004-4172, 7 p.Article

Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for Pre-clinical therapeutic studiesMARTINIELLO-WILKS, Rosetta; DANE, Allison; MORTENSEN, Elin et al.Anticancer research. 2003, Vol 23, Num 3B, pp 2633-2642, issn 0250-7005, 10 p.Article

Farnesyltransferase inhibitors: a novel approach in the treatment of advanced pancreatic carcinomasDEMPKE, Wolfram C. M.Anticancer research. 2003, Vol 23, Num 2A, pp 813-818, issn 0250-7005, 6 p.Conference Paper

Clinical relevance of bioequivalence acceptance criteria: The example of terbinafineKOYTCHEV, Rossen; ERENMEMISOGLU, Aydin; VAN DER MEER, Mike John et al.Arzneimittel-Forschung. 2003, Vol 53, Num 4, pp 289-293, issn 0004-4172, 5 p.Article

Smoking, estradiol metabolism and hormone replacement therapyMUECK, Alfred O; SEEGER, Harald.Arzneimittel-Forschung. 2003, Vol 53, Num 1, pp 1-11, issn 0004-4172, 11 p.Article

Scaling or wider bioequivalence limits for highly variable drugs and for the special case of C_maxTOTHFALUSI, L; ENDRENYI, L; MIDHA, K. K et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 5, pp 217-225, issn 0946-1965, 9 p.Article

Pharmacokinetics and metabolism of radiolabelled SNI-2011, a novel muscarinic receptor agonist, in healthy volunteers comprehensive understanding of absorption, metabolism and excretion using radiolabelled SNI-2011WASHIO, Takuo; KOHSAKA, Kazuhiro; ARISAWA, Hirohiko et al.Arzneimittel-Forschung. 2003, Vol 53, Num 2, pp 80-86, issn 0004-4172, 7 p.Article

Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E)ABDEL REHIM, Wafaa M; SHARAF, Iman A; HISHMAT, Mohamed et al.Arzneimittel-Forschung. 2003, Vol 53, Num 3, pp 214-220, issn 0004-4172, 7 p.Article

Azelastine eye drops in the treatment of perennial allergic conjunctivitisNAZAROV, Ozod; PETZOLD, Ursula; HAASE, Hans et al.Arzneimittel-Forschung. 2003, Vol 53, Num 3, pp 167-173, issn 0004-4172, 7 p.Article

How valid are claims for synergy in published clinical studies?OCANA, A; AMIR, E; YEUNG, C et al.Annals of oncology. 2012, Vol 23, Num 8, pp 2161-2166, issn 0923-7534, 6 p.Article

Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P)DICKNEITE, Gerhard; PRAGST, Ingo; JOCH, Christine et al.Blood coagulation & fibrinolysis. 2009, Vol 20, Num 7, pp 535-540, issn 0957-5235, 6 p.Article

Lessons from randomized phase III studies with active cancer immunotherapies -Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)FINKE, Lothar H; WENTWORTH, Kerry; BLUMENSTEIN, Brent et al.Vaccine. Supplement. 2007, Vol 25, Num 2, issn 1359-5938, B97-B109Article

Pharmacokinetics of three organic nitrates in Chinese healthy male volunteersJUN CHEN; XIN GUO BANG; LEI CAI et al.Arzneimittel-Forschung. 2004, Vol 54, Num 4, pp 203-206, issn 0004-4172, 4 p.Article

The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest painBRÜGGER-ANDERSEN, Trygve; PÖNITZ, Volker; KONTNY, Frederic et al.Thrombosis and haemostasis. 2009, Vol 102, Num 3, pp 555-563, issn 0340-6245, 9 p.Article

Guidelines for optimizing design and analysis of clinical studies of nutrient effectsHEANEY, Robert P.Nutrition reviews. 2014, Vol 72, Num 1, pp 48-54, issn 0029-6643, 7 p.Article

State of Knowledge on Amaranth Grain: A Comprehensive ReviewCASELATO-SOUSA, Valéria Maria; AMAYA-FARFAN, Jaime.Journal of food science. 2012, Vol 77, Num 4-6, issn 0022-1147, R93-R104Article

Clinical outcomes of immediate/early loading of dental implants. A literature review of recent controlled prospective clinical studiesSENNERBY, L; GOTTLOW, J.Australian Dental Journal. 2008, Vol 53, issn 0045-0421, S82-S88, SUP1Article

Effects of low dose chlorhexidine mouthrinses on oral bacteria and salivary microflora including those producing hydrogen sulfideSREENLVASAN, P. K; GITTINS, E.Oral microbiology and immunology. 2004, Vol 19, Num 5, pp 309-313, issn 0902-0055, 5 p.Article

Implementation of proteomic biomarkers: making it workMISCHAK, Harald; IOANNIDIS, John P. A; DYLAG, Tomasz et al.European journal of clinical investigation. 2012, Vol 42, Num 9, pp 1027-1036, issn 0014-2972, 10 p.Article

Concentration-effect relationships of alcohol in a computerised psychometric test SystemVERSAVEL, Mark; ZÜHLSDORF, Michael; UNGER, Sigrun et al.Arzneimittel-Forschung. 2005, Vol 55, Num 5, pp 289-295, issn 0004-4172, 7 p.Article

Implementation of a simple semi-quantitative near-infrared method for the classification of clinical trial tabletsDE MAESSCHALCK, R; VAN DEN KERKHOF, T.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 109-114, issn 0731-7085, 6 p.Article

Statistical guidelines for clinical studies of human visionARMSTRONG, Richard A; DAVIES, Leon N; DUNNE, Mark C. M et al.Ophthalmic & physiological optics. 2011, Vol 31, Num 2, pp 123-136, issn 0275-5408, 14 p.Article

Ribavirin therapeutic drug monitoring: why, when and how?STANKE-LABESQUE, Françoise; LOUSTAUD-RATTI, Véronique; BABANY, Gérard et al.Fundamental & clinical pharmacology. 2010, Vol 24, Num 4, pp 401-406, issn 0767-3981, 6 p.Article

Effects of a mononitrate, a β₁-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis : A placebo-controlled double-blind study in normotensive volunteersYLITALO, Ritva; KÄHÖNEN, Mika; NIEMINEN, Tuomo et al.Arzneimittel-Forschung. 2005, Vol 55, Num 3, pp 160-166, issn 0004-4172, 7 p.Article

Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteersRAHIMY, Mohamad; HALLEN, Bengt; NARANG, Prem et al.Arzneimittel-Forschung. 2002, Vol 52, Num 12, pp 890-895, issn 0004-4172, 6 p.Article